NeoGenomics Laboratories is a medical laboratory that specializes in cancer genetics testing and information services. The company provides testing services to hospitals, pathologists, oncologists, urologists, and other clinicians throughout the United States. NeoGenomics Laboratories was founded in 2001 and is headquartered in Fort Myers, Florida. The company has laboratories in several states, including Florida, Tennessee, and California. NeoGenomics Laboratories is publicly traded on the NASDAQ stock exchange under the ticker symbol NEO.